Retifanlimab-Dlwr

ZYNYZ

Programmed Death Receptor-1 Blocking Antibody

NADAC/unit N/A

No Shortage

Retifanlimab-Dlwr helps the immune system fight cancer by blocking PD-1 immune checkpoints.

Covered Lives

Explore in the Ecosystem

rxsaver.aiCompare prices for Retifanlimab-Dlwr drfinder.aiFind doctors who prescribe Retifanlimab-Dlwr rxnews.aiLatest news about Retifanlimab-Dlwr

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.